A $240 million bio-tech fund

Israel-based venture capital firm Pontifax raised another fund of $240 million – its fifth such fund. Excess demand for the fund saw it closed within two months, and Pontifax is expected to invest most of the money raised in the life-sciences industry.


This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *